Medicine & Life Sciences
Breast Neoplasms
100%
Neoplasms
51%
Transforming Growth Factors
35%
ErbB Receptors
32%
Trastuzumab
26%
Phosphatidylinositol 3-Kinase
26%
Protein-Tyrosine Kinases
23%
Estrogen Receptors
22%
Breast
18%
Mutation
18%
Phosphatidylinositol 3-Kinases
17%
Therapeutics
16%
human ERBB2 protein
16%
Phosphotransferases
15%
Growth
15%
Estrogen Receptor Modulators
15%
Colorectal Neoplasms
15%
Lapatinib
14%
Letrozole
14%
Early Detection of Cancer
14%
Estrogens
13%
Ligands
13%
Triple Negative Breast Neoplasms
12%
Disclosure
11%
Heterografts
10%
Rhabdomyosarcoma
10%
Hormones
9%
Tamoxifen
9%
Epithelial Cells
9%
Phosphorylation
9%
Fulvestrant
9%
Survival
8%
Oncogenes
8%
N-(4-(3-chloro-4-(2-pyridinylmethoxy)anilino)-3-cyano-7-ethoxy-6-quinolyl)-4-(dimethylamino)-2-butenamide
8%
Hispanic Americans
8%
Pharmaceutical Preparations
8%
Clinical Trials
8%
Growth Factor Receptors
8%
Emotions
8%
Cell Line
8%
Biomarkers
8%
ribociclib
7%
Alpelisib
7%
Cell Movement
7%
Gefitinib
7%
Mitogen-Activated Protein Kinase Kinases
7%
NVP-BKM120
7%
Drug Therapy
7%
Receptor Protein-Tyrosine Kinases
7%
Colonoscopy
7%
Antibodies
7%
Neoplasm Metastasis
6%
MCF-7 Cells
6%
Carcinogenesis
6%
Herniorrhaphy
6%
Cancer Survivors
6%
Child
5%
Cell Proliferation
5%
Down-Regulation
5%
Apoptosis
5%
Genes
5%
Cell Survival
5%
Proteins
5%
Inguinal Hernia
5%
IGF Type 1 Receptor
5%
Nude Mice
5%
3-(4-(2-(2-chloro-4-fluorophenyl)-1-(1H-indazol-5-yl)but-1-en-1-yl)phenyl)acrylic acid
5%
Intercellular Signaling Peptides and Proteins
5%
Local Anesthesia
5%
Aromatase Inhibitors
5%
Up-Regulation
5%